Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling, it inhibits androgen-independent prostate cancer cell growth through activation of cell apoptosis and downregulation of androgen receptor expression. Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role against apoptosis through p38-NF-κB survival pathway in A375-S2 cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 998.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 1,250.00 |
Description | Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling, it inhibits androgen-independent prostate cancer cell growth through activation of cell apoptosis and downregulation of androgen receptor expression. Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role against apoptosis through p38-NF-κB survival pathway in A375-S2 cells. |
Source |
Molecular Weight | 526.538 |
Formula | C28H30O10 |
CAS No. | 23027-91-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Physalin A 23027-91-0 Angiogenesis Apoptosis Autophagy Chromatin/Epigenetic Endocrinology/Hormones Immunology/Inflammation JAK/STAT signaling MAPK NF-Κb Stem Cells ROS NF-κB Androgen Receptor p38 MAPK ERK BCL JAK JNK STAT p53 inhibitor inhibit